Recall: Quinapril-Hctz

Nov. 2022Pharmacy Updates
Aurobindo Pharma USA Inc. has recalled two lots of quinapril and hydrochlorothiazide tablets due to detection of a nitrosamine (N-nitrosoquinapril) impurity in amounts above the Acceptable Daily Intake level. Nitrosamines may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time. Read the full text of the Quinapril-Hctz recall.

Recent Announcements

CME Webinar: Oral Health In Your Pediatric Office

Please join us for a live, CME-accredited webinar on Wednesday, Oct. 14 that will provide an overview of oral health in your pediatric office.
Sep. 2026Education/Webinars

Medicaid Renewal

 Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.
Aug. 2026Important Notices

Provider Directory Updates and Required Attestation

As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).
Aug. 2026Important Notices